| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
| Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 8 | 0 | 0 | 8 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 2 | 0 | 2 |
| acid sphingomyelinase | 3 | 0 | 0 | 3 |
| thioredoxin reductase | 22 | 0 | 0 | 22 |
| USP1 protein, partial | 19 | 0 | 0 | 19 |
| TDP1 protein | 42 | 0 | 0 | 42 |
| vitamin D3 receptor isoform VDRA | 11 | 0 | 0 | 11 |
| importin subunit beta-1 isoform 1 | 5 | 0 | 0 | 5 |
| flap endonuclease 1 | 8 | 0 | 0 | 8 |
| serine/threonine-protein kinase PLK1 | 5 | 0 | 0 | 5 |
| snurportin-1 | 5 | 0 | 0 | 5 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 8 | 0 | 0 | 8 |
| GTP-binding nuclear protein Ran isoform 1 | 3 | 0 | 0 | 3 |
| DNA polymerase eta isoform 1 | 5 | 0 | 0 | 5 |
| DNA polymerase iota isoform a (long) | 12 | 0 | 0 | 12 |
| urokinase-type plasminogen activator precursor | 7 | 0 | 0 | 7 |
| plasminogen precursor | 7 | 0 | 0 | 7 |
| urokinase plasminogen activator surface receptor precursor | 7 | 0 | 0 | 7 |
| geminin | 36 | 0 | 0 | 36 |
| DNA polymerase kappa isoform 1 | 8 | 0 | 0 | 8 |
| fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 1 |
| Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Transthyretin | 0 | 1 | 1 | 4 |
| Fatty acid-binding protein, intestinal | 0 | 1 | 1 | 2 |
| Fatty acid-binding protein, adipocyte | 0 | 1 | 1 | 2 |
| Cyclin-A2 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 2 | 1 | 3 |
| Cyclin-dependent kinase 2 | 0 | 1 | 2 | 3 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
| Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
| Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| hypoxia-inducible factor 1 alpha subunit | 15 | 0 | 0 | 15 |
| RAR-related orphan receptor gamma | 33 | 0 | 0 | 33 |
| GLI family zinc finger 3 | 37 | 0 | 0 | 37 |
| AR protein | 52 | 0 | 0 | 52 |
| aldehyde dehydrogenase 1 family, member A1 | 23 | 0 | 0 | 23 |
| retinoic acid nuclear receptor alpha variant 1 | 40 | 0 | 0 | 40 |
| retinoid X nuclear receptor alpha | 34 | 0 | 0 | 34 |
| estrogen nuclear receptor alpha | 50 | 0 | 0 | 50 |
| peroxisome proliferator-activated receptor delta | 20 | 0 | 0 | 20 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 30 | 0 | 0 | 30 |
| activating transcription factor 6 | 14 | 0 | 0 | 14 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 25 | 0 | 0 | 25 |
| Histone H2A.x | 16 | 0 | 0 | 16 |
| thyroid hormone receptor beta isoform a | 12 | 0 | 0 | 12 |
| heat shock protein beta-1 | 14 | 0 | 0 | 14 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 36 | 0 | 0 | 36 |
| lamin isoform A-delta10 | 26 | 0 | 0 | 26 |
| Voltage-dependent calcium channel gamma-2 subunit | 21 | 0 | 0 | 21 |
| Glutamate receptor 2 | 22 | 0 | 0 | 22 |
| Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
| Amyloid-beta precursor protein | 1 | 3 | 0 | 4 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
| Chain A, Heat Shock Protein 90 | 0 | 0 | 1 | 1 |
| Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
| Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
| Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
| Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
| Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
| Chain A, Myosin Ie Heavy Chain | 0 | 0 | 1 | 1 |
| Chain A, Preprotein translocase secA | 0 | 0 | 1 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Phosphoribosylformylglycinamidine synthase | 0 | 1 | 0 | 1 |
| Chain A, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
| Chain B, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
| Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
| Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
| Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
| Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
| Chain A, Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
| regulator of G-protein signaling 4 | 17 | 0 | 0 | 17 |
| HPr kinase/phosphorylase | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
| ATP-dependent molecular chaperone HSP82 | 0 | 0 | 0 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 3 |
| Heat shock protein HSP 90-beta | 0 | 1 | 1 | 3 |
| 2-dehydropantoate 2-reductase | 0 | 1 | 1 | 2 |
| Heat shock 70 kDa protein 1A | 0 | 1 | 1 | 2 |
| Endoplasmic reticulum chaperone BiP | 0 | 0 | 1 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| Pyruvate kinase PKM | 0 | 0 | 0 | 1 |
| Pyruvate kinase PKLR | 0 | 0 | 0 | 1 |
| Endoplasmin | 0 | 0 | 0 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 14 | 3 | 17 |
| Delta-type opioid receptor | 0 | 9 | 2 | 11 |
| Kappa-type opioid receptor | 0 | 13 | 2 | 15 |
| Endoplasmin | 0 | 1 | 1 | 2 |
| P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
| P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
| Inositol monophosphatase 1 | 5 | 0 | 0 | 5 |
| Heat shock protein 75 kDa, mitochondrial | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 6 | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
| P2Y purinoceptor 11 | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
| P2Y purinoceptor 12 | 0 | 0 | 1 | 1 |
| Sensor protein kinase WalK | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
| P2X purinoceptor 2 | 0 | 0 | 1 | 1 |
| glucocorticoid receptor [Homo sapiens] | 45 | 0 | 0 | 45 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 13 | 0 | 0 | 13 |
| Sex hormone-binding globulin | 0 | 0 | 11 | 11 |
| Corticosteroid-binding globulin | 0 | 10 | 0 | 10 |
| Mineralocorticoid receptor | 0 | 3 | 4 | 7 |
| Androgen receptor | 0 | 25 | 0 | 25 |
| Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 3 | 0 | 4 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 20 | 0 | 0 | 20 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 25 | 0 | 0 | 25 |
| estrogen-related nuclear receptor alpha | 43 | 0 | 0 | 43 |
| pregnane X nuclear receptor | 34 | 0 | 0 | 34 |
| IDH1 | 17 | 0 | 0 | 17 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 15 | 0 | 0 | 15 |
| peripheral myelin protein 22 isoform 1 | 7 | 0 | 0 | 7 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 17 | 0 | 0 | 17 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| cytochrome P450 3A4 isoform 1 | 16 | 0 | 0 | 16 |
| Gamma-aminobutyric acid receptor subunit pi | 16 | 1 | 1 | 18 |
| ATP-binding cassette sub-family C member 3 | 0 | 18 | 0 | 18 |
| Multidrug resistance-associated protein 4 | 0 | 18 | 0 | 20 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 35 | 0 | 35 |
| Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 1 | 0 | 1 |
| Triosephosphate isomerase | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 2 | 0 | 2 |
| Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 7 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 16 | 1 | 1 | 18 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | 16 | 1 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 16 | 1 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 16 | 1 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 16 | 1 | 1 | 18 |
| Aromatase | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 16 | 1 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 16 | 1 | 1 | 18 |
| Thromboxane-A synthase | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 16 | 1 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 16 | 1 | 1 | 18 |
| Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 16 | 1 | 1 | 18 |
| Delta-type opioid receptor | 0 | 4 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 16 | 1 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 16 | 1 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 16 | 1 | 1 | 18 |
| GABA theta subunit | 16 | 1 | 1 | 18 |
| Canalicular multispecific organic anion transporter 1 | 0 | 17 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit epsilon | 16 | 1 | 1 | 18 |
| Chain A, HADH2 protein | 15 | 0 | 0 | 15 |
| Chain B, HADH2 protein | 15 | 0 | 0 | 15 |
| interleukin 8 | 8 | 0 | 0 | 8 |
| acetylcholinesterase | 17 | 0 | 0 | 17 |
| SMAD family member 2 | 9 | 0 | 0 | 9 |
| SMAD family member 3 | 9 | 0 | 0 | 9 |
| Smad3 | 4 | 0 | 0 | 4 |
| estrogen receptor 2 (ER beta) | 24 | 0 | 0 | 24 |
| progesterone receptor | 31 | 0 | 0 | 31 |
| nonstructural protein 1 | 7 | 0 | 0 | 7 |
| farnesoid X nuclear receptor | 25 | 0 | 0 | 25 |
| peroxisome proliferator activated receptor gamma | 28 | 0 | 0 | 28 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 25 | 0 | 0 | 25 |
| Caspase-7 | 7 | 0 | 0 | 7 |
| Bloom syndrome protein isoform 1 | 9 | 0 | 0 | 9 |
| caspase-3 | 7 | 0 | 0 | 7 |
| thyroid hormone receptor beta isoform 2 | 37 | 0 | 0 | 37 |
| mitogen-activated protein kinase 1 | 10 | 0 | 0 | 10 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 3 | 0 | 0 | 3 |
| nuclear receptor ROR-gamma isoform 1 | 13 | 0 | 0 | 13 |
| peripheral myelin protein 22 | 16 | 0 | 0 | 16 |
| survival motor neuron protein isoform d | 14 | 0 | 0 | 14 |
| muscleblind-like protein 1 isoform 1 | 6 | 0 | 0 | 6 |
| neuropeptide S receptor isoform A | 4 | 0 | 0 | 4 |
| Beta-glucuronidase | 0 | 2 | 0 | 2 |
| Cholinesterase | 0 | 2 | 0 | 2 |
| Gastrin/cholecystokinin type B receptor | 0 | 0 | 0 | 1 |
| Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 6 | 6 | 0 | 12 |
| Nuclear receptor ROR-gamma | 8 | 0 | 0 | 8 |
| TAR DNA-binding protein 43 | 12 | 0 | 0 | 12 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| phosphopantetheinyl transferase | 20 | 0 | 0 | 20 |
| NFKB1 protein, partial | 7 | 0 | 0 | 7 |
| GLS protein | 16 | 0 | 0 | 16 |
| thyroid stimulating hormone receptor | 15 | 0 | 0 | 15 |
| alpha-galactosidase | 3 | 0 | 0 | 3 |
| euchromatic histone-lysine N-methyltransferase 2 | 32 | 0 | 0 | 32 |
| cytochrome P450 2C19 precursor | 5 | 0 | 0 | 5 |
| chromobox protein homolog 1 | 26 | 0 | 0 | 26 |
| muscarinic acetylcholine receptor M1 | 12 | 0 | 0 | 12 |
| lethal factor (plasmid) | 12 | 0 | 0 | 12 |
| Cytochrome P450 3A4 | 0 | 8 | 0 | 10 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 2 | 0 | 2 |
| ATP-dependent phosphofructokinase | 17 | 0 | 0 | 17 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 5 | 0 | 0 | 5 |
| Polyphenol oxidase 2 | 0 | 4 | 0 | 6 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 2 | 0 | 2 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 21 | 1 | 22 |
| Spike glycoprotein | 13 | 3 | 4 | 20 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 12 | 0 | 0 | 12 |
| Chain A, D-MALTODEXTRIN BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, Limit Dextrinase | 0 | 0 | 1 | 1 |
| Chain A, Solute-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Solute-binding protein | 0 | 0 | 1 | 1 |
| Chain B, SusD | 0 | 0 | 1 | 1 |
| Chain A, SusD | 0 | 0 | 1 | 1 |
| Chain A, SusD | 0 | 0 | 1 | 1 |
| Chain A, Alpha-hemolysin | 0 | 0 | 1 | 1 |
| Chain B, Alpha-hemolysin | 0 | 0 | 1 | 1 |
| Chain C, Alpha-hemolysin | 0 | 0 | 1 | 1 |
| Chain D, Alpha-hemolysin | 0 | 0 | 1 | 1 |
| Chain E, Alpha-hemolysin | 0 | 0 | 1 | 1 |
| Chain F, Alpha-hemolysin | 0 | 0 | 1 | 1 |
| Chain G, Alpha-hemolysin | 0 | 0 | 1 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | 27 | 0 | 0 | 27 |
| thyroid stimulating hormone receptor | 17 | 0 | 0 | 17 |
| Cellular tumor antigen p53 | 29 | 0 | 0 | 29 |
| Genome polyprotein | 0 | 2 | 2 | 4 |
| dopamine D1 receptor | 6 | 0 | 0 | 6 |
| ATAD5 protein, partial | 14 | 0 | 0 | 14 |
| Fumarate hydratase | 10 | 0 | 0 | 10 |
| G | 17 | 0 | 0 | 17 |
| polyprotein | 10 | 0 | 0 | 10 |
| D(1A) dopamine receptor | 10 | 0 | 0 | 10 |
| serine/threonine-protein kinase mTOR isoform 1 | 10 | 0 | 0 | 10 |
| 5-hydroxytryptamine receptor 4 | 0 | 22 | 0 | 22 |
| Interferon beta | 25 | 0 | 0 | 25 |
| HLA class I histocompatibility antigen, B alpha chain | 17 | 0 | 0 | 17 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 7 | 1 | 10 |
| Beta-1 adrenergic receptor | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 1A | 0 | 7 | 2 | 9 |
| Alpha-2A adrenergic receptor | 0 | 25 | 0 | 25 |
| D(2) dopamine receptor | 0 | 23 | 4 | 31 |
| Alpha-2C adrenergic receptor | 0 | 19 | 0 | 19 |
| D | 0 | 11 | 0 | 11 |
| D(3) dopamine receptor | 0 | 11 | 0 | 11 |
| 5-hydroxytryptamine receptor 1A | 0 | 19 | 1 | 20 |
| Alpha-2B adrenergic receptor | 0 | 7 | 0 | 7 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 18 | 0 | 20 |
| Alpha-2C adrenergic receptor | 0 | 7 | 0 | 7 |
| Alpha-2A adrenergic receptor | 0 | 7 | 0 | 7 |
| Alpha-1D adrenergic receptor | 0 | 18 | 0 | 18 |
| D(1B) dopamine receptor | 0 | 11 | 0 | 11 |
| 5-hydroxytryptamine receptor 2A | 0 | 24 | 2 | 26 |
| 5-hydroxytryptamine receptor 2C | 0 | 25 | 2 | 27 |
| 5-hydroxytryptamine receptor 1B | 0 | 20 | 0 | 20 |
| D(4) dopamine receptor | 0 | 11 | 0 | 11 |
| D(3) dopamine receptor | 0 | 24 | 2 | 31 |
| 5-hydroxytryptamine receptor 2B | 0 | 26 | 0 | 26 |
| 5-hydroxytryptamine receptor 6 | 0 | 20 | 0 | 20 |
| D(2) dopamine receptor | 0 | 17 | 2 | 20 |
| Inositol hexakisphosphate kinase 1 | 17 | 0 | 0 | 17 |
| ATPase family AAA domain-containing protein 5 | 12 | 0 | 0 | 12 |
| Ataxin-2 | 17 | 0 | 0 | 17 |
| cytochrome P450 2C9, partial | 17 | 0 | 0 | 17 |
| nuclear receptor subfamily 1, group I, member 2 | 5 | 0 | 0 | 5 |
| Lactoperoxidase | 0 | 2 | 0 | 2 |
| EWS/FLI fusion protein | 13 | 0 | 0 | 13 |
| cytochrome P450 2D6 | 15 | 0 | 0 | 15 |
| aryl hydrocarbon receptor | 15 | 0 | 0 | 15 |
| streptokinase A precursor | 0 | 0 | 3 | 3 |
| Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
| 30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
| Methionine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 1 | 0 | 7 | 0 | 10 |
| Carbonic anhydrase 2 | 0 | 7 | 1 | 12 |
| Carbonic anhydrase 4 | 0 | 4 | 0 | 6 |
| Carbonic anhydrase | 0 | 2 | 0 | 4 |
| Carbonic anhydrase 15 | 0 | 5 | 0 | 7 |
| PPM1D protein | 8 | 0 | 0 | 8 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 2 | 0 | 2 |
| Spike glycoprotein | 0 | 3 | 4 | 7 |
| Replicase polyprotein 1ab | 0 | 4 | 4 | 8 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 2 | 0 | 2 |
| Transmembrane protease serine 2 | 0 | 3 | 4 | 7 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| DNA ligase | 0 | 1 | 0 | 1 |
| Riboflavin-binding protein | 0 | 0 | 1 | 1 |
| Major prion protein | 0 | 0 | 3 | 3 |
| Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 2 |
| Procathepsin L | 0 | 3 | 4 | 7 |
| Muscarinic acetylcholine receptor M2 | 0 | 14 | 0 | 14 |
| Muscarinic acetylcholine receptor M4 | 0 | 14 | 0 | 14 |
| Muscarinic acetylcholine receptor M5 | 0 | 13 | 0 | 13 |
| Replicase polyprotein 1a | 0 | 3 | 4 | 7 |
| Replicase polyprotein 1ab | 0 | 3 | 4 | 7 |
| Replicase polyprotein 1ab | 0 | 3 | 4 | 7 |
| Spike glycoprotein | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 5 | 4 | 9 |
| Muscarinic acetylcholine receptor M1 | 0 | 17 | 0 | 17 |
| DNA ligase 1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 16 | 0 | 16 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Beta-secretase 1 | 0 | 1 | 0 | 1 |
| Calcium-dependent protein kinase 1 | 0 | 0 | 1 | 1 |
| MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
| DNA ligase A | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 16 | 0 | 16 |
| Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
| Phosphoethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 15 | 0 | 15 |
| Angiotensin-converting enzyme 2 | 0 | 3 | 4 | 7 |
| Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
| Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 13 | 0 | 0 | 13 |
| Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
| Microtubule-associated protein tau | 14 | 0 | 0 | 14 |
| Thrombopoietin | 7 | 0 | 0 | 7 |
| caspase 7, apoptosis-related cysteine protease | 8 | 0 | 0 | 8 |
| NADPH oxidase 1 | 0 | 2 | 0 | 2 |
| 67.9K protein | 8 | 0 | 0 | 8 |
| Snq2p | 0 | 0 | 0 | 3 |
| caspase-3 | 8 | 0 | 0 | 8 |
| Adenylate cyclase type 1 | 0 | 3 | 0 | 3 |
| cytochrome P450 2D6 isoform 1 | 6 | 0 | 0 | 6 |
| cellular tumor antigen p53 isoform a | 10 | 0 | 0 | 10 |
| histone deacetylase 9 isoform 3 | 4 | 0 | 0 | 4 |
| atrial natriuretic peptide receptor 2 precursor | 3 | 0 | 0 | 3 |
| ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
| M-phase phosphoprotein 8 | 7 | 0 | 0 | 7 |
| Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 6 | 0 | 8 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 9 | 0 | 0 | 9 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 1 | 4 |
| Bile salt export pump | 0 | 6 | 0 | 6 |
| Potassium channel subfamily K member 2 | 0 | 3 | 2 | 5 |
| Epidermal growth factor receptor | 0 | 9 | 0 | 9 |
| Albumin | 0 | 2 | 2 | 4 |
| Albumin | 0 | 0 | 5 | 5 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 3 | 0 | 3 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 4 | 0 | 4 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Integrin beta-3 | 8 | 0 | 0 | 8 |
| Cytochrome P450 1A2 | 0 | 2 | 1 | 3 |
| Tyrosine-protein kinase Fyn | 0 | 7 | 0 | 7 |
| Aldo-keto reductase family 1 member B1 | 0 | 20 | 0 | 20 |
| Muscarinic acetylcholine receptor M1 | 0 | 5 | 0 | 5 |
| Muscarinic acetylcholine receptor M3 | 0 | 5 | 0 | 5 |
| Muscarinic acetylcholine receptor M4 | 0 | 5 | 0 | 5 |
| Integrin alpha-IIb | 8 | 0 | 0 | 8 |
| 5-hydroxytryptamine receptor 2C | 0 | 10 | 0 | 11 |
| Muscarinic acetylcholine receptor M5 | 0 | 5 | 0 | 5 |
| Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
| Calmodulin-1 | 0 | 2 | 1 | 3 |
| Cytochrome P450 2D6 | 0 | 8 | 1 | 9 |
| Muscarinic acetylcholine receptor M2 | 0 | 5 | 0 | 5 |
| Cytochrome P450 2C9 | 0 | 9 | 1 | 10 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 6 | 0 | 6 |
| Angiotensin-converting enzyme | 0 | 11 | 0 | 11 |
| 5-hydroxytryptamine receptor 2A | 0 | 11 | 0 | 11 |
| Alpha-1B adrenergic receptor | 0 | 18 | 0 | 18 |
| Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 5 | 0 | 5 |
| Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
| Substance-K receptor | 0 | 10 | 0 | 10 |
| D(4) dopamine receptor | 0 | 11 | 1 | 15 |
| D(1B) dopamine receptor | 0 | 4 | 0 | 6 |
| Adenylate cyclase type 3 | 0 | 3 | 0 | 3 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 5 |
| Alpha-1D adrenergic receptor | 0 | 8 | 0 | 8 |
| Sodium-dependent noradrenaline transporter | 0 | 22 | 0 | 22 |
| Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
| Histamine H2 receptor | 0 | 13 | 2 | 15 |
| Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
| Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
| Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
| Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
| Adenylate cyclase type 2 | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 4 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
| Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
| Trypanothione reductase | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2B | 0 | 8 | 0 | 8 |
| Histamine H1 receptor | 0 | 2 | 3 | 5 |
| Sodium-dependent serotonin transporter | 0 | 27 | 0 | 27 |
| Melanocortin receptor 4 | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 7 | 0 | 5 | 0 | 5 |
| Melanocortin receptor 5 | 0 | 6 | 0 | 6 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 3 | 0 | 6 |
| 5-hydroxytryptamine receptor 7 | 0 | 8 | 0 | 10 |
| Histamine H1 receptor | 0 | 12 | 3 | 15 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 5 | 2 | 9 |
| Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 8 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
| Melanocortin receptor 3 | 0 | 4 | 0 | 4 |
| Alpha-1A adrenergic receptor | 0 | 18 | 0 | 18 |
| Histamine H2 receptor | 10 | 0 | 1 | 12 |
| Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
| Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 4 | 1 | 0 | 5 |
| 5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 4 |
| Cytochrome P450 2J2 | 0 | 4 | 0 | 4 |
| Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
| Proteasome subunit alpha type-6 | 0 | 0 | 2 | 3 |
| Calmodulin | 0 | 1 | 1 | 2 |
| Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 5 | 1 | 8 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 5 | 2 | 9 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 5 | 1 | 8 |
| Sodium channel protein type 7 subunit alpha | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 1 | 4 |
| Sodium-dependent dopamine transporter | 0 | 16 | 0 | 16 |
| Adenylate cyclase type 6 | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 5 | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Aldehyde oxidase | 0 | 4 | 0 | 6 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 1 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 1 | 4 |
| Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 5 | 1 | 8 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 10 | 0 | 10 |
| Adenylyl cyclase 7 | 0 | 3 | 0 | 3 |
| Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 5 | 1 | 8 |
| D | 0 | 3 | 0 | 3 |
| Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
| Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 5 | 1 | 8 |
| Sodium channel protein type 11 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 8 subunit alpha | 0 | 2 | 0 | 2 |
| Histamine H3 receptor | 0 | 3 | 2 | 5 |
| Sodium channel protein type 10 subunit alpha | 0 | 2 | 0 | 2 |
| pregnane X receptor | 8 | 0 | 0 | 8 |
| GALC protein | 7 | 0 | 0 | 7 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 7 | 0 | 0 | 7 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 3 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
| C-8 sterol isomerase | 0 | 4 | 0 | 4 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 5 | 1 | 6 |
| Solute carrier family 22 member 1 | 0 | 3 | 0 | 4 |
| Solute carrier family 22 member 2 | 0 | 4 | 0 | 5 |
| endonuclease IV | 5 | 0 | 0 | 5 |
| atrial natriuretic peptide receptor 1 precursor | 4 | 0 | 0 | 4 |
| Glucocorticoid receptor | 0 | 16 | 2 | 23 |
| Glycine receptor subunit alpha-1 | 0 | 16 | 0 | 16 |
| Glycine receptor subunit beta | 0 | 16 | 0 | 16 |
| Glycine receptor subunit alpha-2 | 0 | 16 | 0 | 16 |
| Glycine receptor subunit alpha-3 | 0 | 16 | 0 | 16 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
| bromodomain adjacent to zinc finger domain 2B | 10 | 0 | 0 | 10 |
| arylsulfatase A | 9 | 0 | 0 | 9 |
| Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 4 | 0 | 5 |
| huntingtin isoform 2 | 4 | 0 | 0 | 4 |
| chaperonin GroEL | 1 | 0 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, brain form | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Endothelin receptor type B | 1 | 2 | 0 | 3 |
| Endothelin receptor type B | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Histone-lysine N-methyltransferase SETD7 | 0 | 2 | 0 | 2 |
| Transporter | 0 | 2 | 0 | 2 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Vasopressin V1a receptor | 0 | 3 | 1 | 4 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 3 | 0 | 3 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
| Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
| CREB-binding protein | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
| Luciferase | 12 | 0 | 0 | 12 |
| cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
| NAD | 0 | 1 | 0 | 1 |
| NAD | 0 | 1 | 0 | 2 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| ATP phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
| Chain A, Ferritin light chain | 5 | 0 | 0 | 5 |
| glp-1 receptor, partial | 10 | 0 | 0 | 10 |
| 15-lipoxygenase, partial | 9 | 0 | 0 | 9 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 4 | 0 | 0 | 4 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
| high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 1 | 0 | 3 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 1 | 2 | 3 |
| Estrogen receptor | 0 | 18 | 4 | 24 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 2 |
| Adenosine receptor A3 | 0 | 10 | 0 | 10 |
| Acetylcholinesterase | 0 | 4 | 1 | 5 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
| Adenosine receptor A2a | 0 | 6 | 0 | 6 |
| Adenosine receptor A1 | 0 | 6 | 0 | 6 |
| Estrogen-related receptor gamma | 0 | 1 | 1 | 2 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
| UDP-glucose 4-epimerase | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 8 | 4 | 13 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 4 |
| Cysteinyl leukotriene receptor 1 | 0 | 2 | 0 | 2 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 6 | 0 | 0 | 6 |
| Chain A, 2-oxoglutarate Oxygenase | 7 | 0 | 0 | 7 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 5 | 0 | 0 | 5 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 3 | 0 | 0 | 3 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
| runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
| core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Chain A, Beta-lactamase | 8 | 0 | 0 | 8 |
| chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
| ubiquitin-conjugating enzyme E2 N | 0 | 2 | 0 | 2 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 6 | 0 | 6 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| Proenkephalin-B | 0 | 0 | 1 | 1 |
| Delta-type opioid receptor | 0 | 4 | 0 | 4 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 4 | 1 | 5 |
| Kappa-type opioid receptor | 0 | 3 | 0 | 3 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 3 | 1 | 4 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| hypothetical protein, conserved | 3 | 0 | 0 | 3 |
| thyrotropin-releasing hormone receptor | 4 | 0 | 0 | 4 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
| large T antigen | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 4 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
| UDP-glucuronosyltransferase 1A10 | 0 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 3 | 0 | 0 | 3 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| glucokinase regulatory protein | 3 | 0 | 0 | 3 |
| Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
| Steryl-sulfatase | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 2 | 0 | 3 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Ghrelin O-acyltransferase | 0 | 1 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 5 | 0 | 0 | 5 |
| Vpr | 4 | 0 | 0 | 4 |
| Cytochrome P450 2B1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 3 | 0 | 0 | 3 |
| Neuronal acetylcholine receptor subunit beta-2 | 3 | 0 | 0 | 3 |
| Cytochrome P450 2B6 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 3 | 0 | 4 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Sulfotransferase 1A1 | 0 | 2 | 1 | 4 |
| Nuclear receptor subfamily 1 group I member 3 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 2 |
| Sodium/nucleoside cotransporter 2 | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 5 | 0 | 5 |
| Thymidine phosphorylase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
| Thymidine kinase | 0 | 0 | 0 | 1 |
| Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Skn7p | 0 | 0 | 0 | 1 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
| glucocerebrosidase | 6 | 0 | 0 | 6 |
| Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| Thymidylate synthase | 0 | 4 | 0 | 4 |
| Dihydrofolate reductase | 0 | 2 | 3 | 5 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 4 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 4 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 3 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 3 | 0 | 3 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
| Vitamin D-binding protein | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 1 | 0 | 3 |
| Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 1F | 0 | 3 | 0 | 3 |
| Histamine H1 receptor | 0 | 5 | 1 | 6 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
| N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 2 | 0 | 2 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
| Zinc finger protein 664 | 0 | 1 | 0 | 1 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Transporter | 0 | 2 | 0 | 2 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Protease | 0 | 2 | 0 | 2 |
| Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| WRN | 2 | 0 | 0 | 2 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| MPI protein | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
| alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
| apical membrane antigen 1, AMA1 | 7 | 0 | 0 | 7 |
| luciferase | 1 | 0 | 0 | 1 |
| pyruvate kinase | 2 | 0 | 0 | 2 |
| CDK5 | 0 | 0 | 0 | 1 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 0 | 1 | 1 |
| intestinal alkaline phosphatase precursor | 0 | 0 | 1 | 1 |
| Vif | 0 | 1 | 0 | 1 |
| Tat | 0 | 1 | 0 | 1 |
| alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
| endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 2 | 0 | 2 |
| Endothelin-1 receptor | 1 | 0 | 0 | 1 |
| phosphoglycerate kinase | 2 | 0 | 0 | 2 |
| hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 2 |
| H3 histone acetyltransferase | 0 | 0 | 0 | 2 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
| aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
| transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 3 | 0 | 5 |
| Plasma kallikrein | 0 | 0 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 3 | 0 | 5 |
| Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 6 | 0 | 3 | 0 | 5 |
| 5-hydroxytryptamine receptor 1D | 0 | 2 | 1 | 5 |
| Adenosine receptor A2a | 0 | 0 | 0 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 5 |
| Carbonic anhydrase 7 | 0 | 3 | 0 | 5 |
| Carbonic anhydrase | 0 | 1 | 0 | 4 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 3 | 0 | 6 |
| Carbonic anhydrase | 0 | 1 | 0 | 4 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 4 |
| Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 4 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 2 | 0 | 4 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 5 |
| Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
| Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
| Amino acid transporter | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Lysosomal protective protein | 0 | 1 | 0 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| Liver carboxylesterase | 0 | 1 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 2 | 0 | 2 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
| cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 3B | 0 | 5 | 0 | 5 |
| Dopamine beta-hydroxylase | 0 | 2 | 0 | 2 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 2 | 0 | 2 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 0 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 1 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3E | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 1 | 2 |
| Myeloperoxidase | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 1 | 2 |
| Lactoperoxidase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 3 |
| 5-hydroxytryptamine receptor 3D | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 3C | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 3 | 0 | 3 |
| Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
| Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
| Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
| Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
| D-amino-acid oxidase | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| Hydroxycarboxylic acid receptor 3 | 0 | 0 | 1 | 1 |
| Nicotinamidase | 0 | 1 | 0 | 1 |
| Hydroxycarboxylic acid receptor 2 | 0 | 0 | 1 | 1 |
| Hydroxycarboxylic acid receptor 2 | 0 | 2 | 1 | 3 |
| D-aspartate oxidase | 0 | 1 | 0 | 1 |
| Hydroxycarboxylic acid receptor 2 | 0 | 1 | 1 | 2 |
| Chain A, NAD-dependent deacetylase | 0 | 1 | 0 | 1 |
| Poly [ADP-ribose] polymerase 2 | 0 | 1 | 0 | 1 |
| NAD-dependent histone deacetylase SIR2 | 0 | 1 | 0 | 1 |
| Coagulation factor VII | 0 | 1 | 0 | 1 |
| Poly [ADP-ribose] polymerase 1 | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase HST2 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
| NAD(+) hydrolase SARM1 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-6 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase | 0 | 1 | 0 | 1 |
| Parkin | 2 | 0 | 0 | 2 |
| tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 2 | 3 |
| Progesterone receptor | 0 | 5 | 2 | 8 |
| Estrogen receptor beta | 0 | 0 | 2 | 3 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 2 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 2 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
| beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 3 | 0 | 3 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 2 |
| heat shock protein 90, putative | 0 | 0 | 0 | 2 |
| NADH-cytochrome b5 reductase 3 | 0 | 1 | 0 | 1 |
| Thyroid peroxidase | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 38 | 0 | 0 | 1 | 2 |
| Chain A, PUTRESCINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN | 0 | 1 | 0 | 1 |
| Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN | 0 | 1 | 0 | 1 |
| Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN | 0 | 1 | 0 | 1 |
| Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN | 0 | 1 | 0 | 1 |
| Ornithine decarboxylase | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 3 | 0 | 3 |
| S-adenosylmethionine decarboxylase proenzyme | 0 | 0 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 3 | 0 | 3 |
| DNA topoisomerase 2-alpha | 0 | 2 | 0 | 2 |
| Sulfate anion transporter 1 | 0 | 0 | 0 | 1 |
| Caspase-2 | 0 | 0 | 1 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| NAD(P)H dehydrogenase [quinone] 1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Carboxypeptidase M | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 1E | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1F | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| Chain A, CES1 protein | 0 | 1 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
| Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 1 |
| Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
| Protein kinase C gamma type | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| Protein kinase C beta type | 0 | 1 | 0 | 1 |
| Protein kinase C delta type | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
| Protein kinase C zeta type | 0 | 1 | 0 | 1 |
| Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
| Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| Protein kinase C eta type | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| B2 bradykinin receptor | 0 | 2 | 0 | 2 |
| Protein kinase C iota type | 0 | 1 | 0 | 1 |
| Protein kinase C gamma type | 0 | 1 | 0 | 1 |
| Protein kinase C beta type | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
| Protein kinase C theta type | 0 | 1 | 0 | 1 |
| Protein kinase C zeta type | 0 | 1 | 0 | 1 |
| Protein kinase C delta type | 0 | 1 | 0 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 1 |
| Protein kinase C eta type | 0 | 1 | 0 | 1 |
| Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
| 7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
| Protein kinase C theta type | 0 | 1 | 0 | 1 |
| Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
| Cathepsin D | 0 | 1 | 0 | 1 |
| Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0 | 1 | 0 | 1 |
| Janus kinase 2 (a protein tyrosine kinase) | 0 | 1 | 0 | 1 |
| fructose-bisphosphate aldolase A | 1 | 0 | 0 | 1 |
| glyceraldehyde-3-phosphate dehydrogenase isoform 1 | 1 | 0 | 0 | 1 |
| E3 ubiquitin-protein ligase Mdm2 isoform a | 0 | 0 | 1 | 1 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Gamma-butyrobetaine dioxygenase | 0 | 1 | 1 | 2 |
| Retinal dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Aldehyde dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 0 | 1 | 1 |
| Protein-lysine 6-oxidase | 0 | 1 | 0 | 1 |
| Lysyl oxidase homolog 3 | 0 | 1 | 0 | 1 |
| Lysyl oxidase homolog 4 | 0 | 1 | 0 | 1 |
| Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
| Monoglyceride lipase | 0 | 1 | 0 | 1 |
| Histone-lysine N-methyltransferase EHMT1 | 0 | 1 | 0 | 1 |
| Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 3 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
| Thyroid hormone receptor alpha | 0 | 2 | 3 | 5 |
| Thyroid hormone receptor beta | 0 | 2 | 3 | 5 |
| Proliferating cell nuclear antigen | 0 | 2 | 0 | 2 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 2 | 2 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 4 | 4 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 2 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
| Guanine deaminase | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |